Effects of recombinant human IGF-I on glucose and leucine kinetics in men

D. Elahi, M. McAloon-Dyke, N. K. Fukagawa, A. L. Sclater, G. A. Wong, R. P. Shannon, K. L. Minaker, J. M. Miles, A. H. Rubenstein, C. J. Vandepol, H. P. Guler, W. R. Good, J. J. Seaman, R. R. Wolfe

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

To examine the effects of recombinant human (rh) insulin-like growth factor I (IGF-I), insulin, and saline on metabolic parameters, we studied 20 young nonobese healthy men. Euglycemic clamps with 240-min IGF-I infusions at two doses (49 and 33 pmol · kg-1 · min-1, n = 8 and 12 subjects) were performed and compared with hyperinsulinemic-euglycemic clamps (2.25 pmol · kg-1 · min-1, n = 9). Leucine and glucose kinetics were examined with L- [1-13C]leucine and [3-3H]glucose. Glucose rate of appearance (R(a)) declined equivalently in the 49 pmol · kg-1 · min-1 IGF-I and insulin clamps but remained at basal levels during the 33 pmol · kg-1 · min-1 IGF-I infusions. In contrast, R(d) of glucose was increased by 176% in the 49 pmol · kg-1 · min-1 IGF-I and 78% in the 33 pmol · kg-1 · min-1 IGF-I infusions. Furthermore, to prevent hypoglycemia after the termination of both rhIGF-I infusions, it was necessary to infuse glucose for an additional 2-20 h. R(a) of leucine was suppressed significantly by both IGF- I and insulin, whereas leucine oxidation was not affected by either hormone. Therefore, the rate of disappearance of leucine expressed as the difference between R(a) and oxidation rates was significantly reduced in all clamps. In addition, IGF-I significantly suppressed β-cell secretion without affecting the other glucoregulatory hormones. In contrast to insulin, IGF-I had no apparent effect on lipolysis, as measured by changes in nonesterified fatty acids. These data suggest that, in healthy men, 1) rhIGF-I infusions suppress proteolysis and stimulate glucose uptake in a qualitatively similar manner to insulin; 2) there is differential tissue and substrate sensitivity to IGF-I; and 3) the effect of IGF-I on glucose utilization is more prolonged compared with that of insulin.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume265
Issue number6 28-6
StatePublished - 1993
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor I
Leucine
Glucose
Kinetics
Clamping devices
Insulin
Glucose Clamp Technique
Hormones
Proteolysis
Oxidation
Lipolysis
Hypoglycemia
Nonesterified Fatty Acids
Tissue

Keywords

  • amino acid metabolism
  • glucose metabolism
  • isotope tracers
  • nonesterified fatty acid
  • pancreatic secretion

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Elahi, D., McAloon-Dyke, M., Fukagawa, N. K., Sclater, A. L., Wong, G. A., Shannon, R. P., ... Wolfe, R. R. (1993). Effects of recombinant human IGF-I on glucose and leucine kinetics in men. American Journal of Physiology - Endocrinology and Metabolism, 265(6 28-6).

Effects of recombinant human IGF-I on glucose and leucine kinetics in men. / Elahi, D.; McAloon-Dyke, M.; Fukagawa, N. K.; Sclater, A. L.; Wong, G. A.; Shannon, R. P.; Minaker, K. L.; Miles, J. M.; Rubenstein, A. H.; Vandepol, C. J.; Guler, H. P.; Good, W. R.; Seaman, J. J.; Wolfe, R. R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 265, No. 6 28-6, 1993.

Research output: Contribution to journalArticle

Elahi, D, McAloon-Dyke, M, Fukagawa, NK, Sclater, AL, Wong, GA, Shannon, RP, Minaker, KL, Miles, JM, Rubenstein, AH, Vandepol, CJ, Guler, HP, Good, WR, Seaman, JJ & Wolfe, RR 1993, 'Effects of recombinant human IGF-I on glucose and leucine kinetics in men', American Journal of Physiology - Endocrinology and Metabolism, vol. 265, no. 6 28-6.
Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, Shannon RP et al. Effects of recombinant human IGF-I on glucose and leucine kinetics in men. American Journal of Physiology - Endocrinology and Metabolism. 1993;265(6 28-6).
Elahi, D. ; McAloon-Dyke, M. ; Fukagawa, N. K. ; Sclater, A. L. ; Wong, G. A. ; Shannon, R. P. ; Minaker, K. L. ; Miles, J. M. ; Rubenstein, A. H. ; Vandepol, C. J. ; Guler, H. P. ; Good, W. R. ; Seaman, J. J. ; Wolfe, R. R. / Effects of recombinant human IGF-I on glucose and leucine kinetics in men. In: American Journal of Physiology - Endocrinology and Metabolism. 1993 ; Vol. 265, No. 6 28-6.
@article{3f366ce0d0d946cab805f60129345a68,
title = "Effects of recombinant human IGF-I on glucose and leucine kinetics in men",
abstract = "To examine the effects of recombinant human (rh) insulin-like growth factor I (IGF-I), insulin, and saline on metabolic parameters, we studied 20 young nonobese healthy men. Euglycemic clamps with 240-min IGF-I infusions at two doses (49 and 33 pmol · kg-1 · min-1, n = 8 and 12 subjects) were performed and compared with hyperinsulinemic-euglycemic clamps (2.25 pmol · kg-1 · min-1, n = 9). Leucine and glucose kinetics were examined with L- [1-13C]leucine and [3-3H]glucose. Glucose rate of appearance (R(a)) declined equivalently in the 49 pmol · kg-1 · min-1 IGF-I and insulin clamps but remained at basal levels during the 33 pmol · kg-1 · min-1 IGF-I infusions. In contrast, R(d) of glucose was increased by 176{\%} in the 49 pmol · kg-1 · min-1 IGF-I and 78{\%} in the 33 pmol · kg-1 · min-1 IGF-I infusions. Furthermore, to prevent hypoglycemia after the termination of both rhIGF-I infusions, it was necessary to infuse glucose for an additional 2-20 h. R(a) of leucine was suppressed significantly by both IGF- I and insulin, whereas leucine oxidation was not affected by either hormone. Therefore, the rate of disappearance of leucine expressed as the difference between R(a) and oxidation rates was significantly reduced in all clamps. In addition, IGF-I significantly suppressed β-cell secretion without affecting the other glucoregulatory hormones. In contrast to insulin, IGF-I had no apparent effect on lipolysis, as measured by changes in nonesterified fatty acids. These data suggest that, in healthy men, 1) rhIGF-I infusions suppress proteolysis and stimulate glucose uptake in a qualitatively similar manner to insulin; 2) there is differential tissue and substrate sensitivity to IGF-I; and 3) the effect of IGF-I on glucose utilization is more prolonged compared with that of insulin.",
keywords = "amino acid metabolism, glucose metabolism, isotope tracers, nonesterified fatty acid, pancreatic secretion",
author = "D. Elahi and M. McAloon-Dyke and Fukagawa, {N. K.} and Sclater, {A. L.} and Wong, {G. A.} and Shannon, {R. P.} and Minaker, {K. L.} and Miles, {J. M.} and Rubenstein, {A. H.} and Vandepol, {C. J.} and Guler, {H. P.} and Good, {W. R.} and Seaman, {J. J.} and Wolfe, {R. R.}",
year = "1993",
language = "English (US)",
volume = "265",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6 28-6",

}

TY - JOUR

T1 - Effects of recombinant human IGF-I on glucose and leucine kinetics in men

AU - Elahi, D.

AU - McAloon-Dyke, M.

AU - Fukagawa, N. K.

AU - Sclater, A. L.

AU - Wong, G. A.

AU - Shannon, R. P.

AU - Minaker, K. L.

AU - Miles, J. M.

AU - Rubenstein, A. H.

AU - Vandepol, C. J.

AU - Guler, H. P.

AU - Good, W. R.

AU - Seaman, J. J.

AU - Wolfe, R. R.

PY - 1993

Y1 - 1993

N2 - To examine the effects of recombinant human (rh) insulin-like growth factor I (IGF-I), insulin, and saline on metabolic parameters, we studied 20 young nonobese healthy men. Euglycemic clamps with 240-min IGF-I infusions at two doses (49 and 33 pmol · kg-1 · min-1, n = 8 and 12 subjects) were performed and compared with hyperinsulinemic-euglycemic clamps (2.25 pmol · kg-1 · min-1, n = 9). Leucine and glucose kinetics were examined with L- [1-13C]leucine and [3-3H]glucose. Glucose rate of appearance (R(a)) declined equivalently in the 49 pmol · kg-1 · min-1 IGF-I and insulin clamps but remained at basal levels during the 33 pmol · kg-1 · min-1 IGF-I infusions. In contrast, R(d) of glucose was increased by 176% in the 49 pmol · kg-1 · min-1 IGF-I and 78% in the 33 pmol · kg-1 · min-1 IGF-I infusions. Furthermore, to prevent hypoglycemia after the termination of both rhIGF-I infusions, it was necessary to infuse glucose for an additional 2-20 h. R(a) of leucine was suppressed significantly by both IGF- I and insulin, whereas leucine oxidation was not affected by either hormone. Therefore, the rate of disappearance of leucine expressed as the difference between R(a) and oxidation rates was significantly reduced in all clamps. In addition, IGF-I significantly suppressed β-cell secretion without affecting the other glucoregulatory hormones. In contrast to insulin, IGF-I had no apparent effect on lipolysis, as measured by changes in nonesterified fatty acids. These data suggest that, in healthy men, 1) rhIGF-I infusions suppress proteolysis and stimulate glucose uptake in a qualitatively similar manner to insulin; 2) there is differential tissue and substrate sensitivity to IGF-I; and 3) the effect of IGF-I on glucose utilization is more prolonged compared with that of insulin.

AB - To examine the effects of recombinant human (rh) insulin-like growth factor I (IGF-I), insulin, and saline on metabolic parameters, we studied 20 young nonobese healthy men. Euglycemic clamps with 240-min IGF-I infusions at two doses (49 and 33 pmol · kg-1 · min-1, n = 8 and 12 subjects) were performed and compared with hyperinsulinemic-euglycemic clamps (2.25 pmol · kg-1 · min-1, n = 9). Leucine and glucose kinetics were examined with L- [1-13C]leucine and [3-3H]glucose. Glucose rate of appearance (R(a)) declined equivalently in the 49 pmol · kg-1 · min-1 IGF-I and insulin clamps but remained at basal levels during the 33 pmol · kg-1 · min-1 IGF-I infusions. In contrast, R(d) of glucose was increased by 176% in the 49 pmol · kg-1 · min-1 IGF-I and 78% in the 33 pmol · kg-1 · min-1 IGF-I infusions. Furthermore, to prevent hypoglycemia after the termination of both rhIGF-I infusions, it was necessary to infuse glucose for an additional 2-20 h. R(a) of leucine was suppressed significantly by both IGF- I and insulin, whereas leucine oxidation was not affected by either hormone. Therefore, the rate of disappearance of leucine expressed as the difference between R(a) and oxidation rates was significantly reduced in all clamps. In addition, IGF-I significantly suppressed β-cell secretion without affecting the other glucoregulatory hormones. In contrast to insulin, IGF-I had no apparent effect on lipolysis, as measured by changes in nonesterified fatty acids. These data suggest that, in healthy men, 1) rhIGF-I infusions suppress proteolysis and stimulate glucose uptake in a qualitatively similar manner to insulin; 2) there is differential tissue and substrate sensitivity to IGF-I; and 3) the effect of IGF-I on glucose utilization is more prolonged compared with that of insulin.

KW - amino acid metabolism

KW - glucose metabolism

KW - isotope tracers

KW - nonesterified fatty acid

KW - pancreatic secretion

UR - http://www.scopus.com/inward/record.url?scp=0027760887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027760887&partnerID=8YFLogxK

M3 - Article

C2 - 8279537

AN - SCOPUS:0027760887

VL - 265

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6 28-6

ER -